21 results for author:"Vionnet N." in Literature citations
Results Customize
› Repeat search in UniProtKB (6)
| A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women. Mollsten A., Vionnet N., Forsblom C., Parkkonen M., Tarnow L., Hadjadj S., Marre M., Parving H.H., Groop P.H. Mol. Genet. Metab. 103:66-70(2011) · Mapped (5) |
| A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus. Alkhalaf A., Bakker S.J., Bilo H.J., Gans R.O., Navis G.J., Postmus D., Forsblom C., Groop P.H., Vionnet N., Hadjadj S. et al. Diabetologia 53:2562-2568(2010) · Mapped (3) |
| The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes. Mollsten A., Jorsal A., Lajer M., Vionnet N., Tarnow L. Diabetologia 52:2590-2593(2009) · Mapped (13) |
| G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes. EURAGEDIC Consortium Diabetes 57:2843-2850(2008) · Mapped (5) |
| Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Jorsal A., Tarnow L., Frystyk J., Lajer M., Flyvbjerg A., Parving H.H., Vionnet N., Rossing P. Kidney Int. 74:649-654(2008) · Mapped (3) |
| Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene. Vionnet N., Tregouet D., Kazeem G., Gut I., Groop P.H., Tarnow L., Parving H.H., Hadjadj S., Forsblom C., Farrall M. et al. Diabetes 55:3166-3174(2006) · Mapped (15) |
| Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome. Kaisaki P.J., Delepine M., Woon P.Y., Sebag-Montefiore L., Wilder S.P., Menzel S., Vionnet N., Marion E., Riveline J.-P., Charpentier G. et al. |
| The gene, MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Waeber G., Delplanque J., Bonny C., Mooser V., Steinmann M., Widmann C., Maillard A., Miklossy J., Dina C., Hani E.H. et al. Nat. Genet. 24:291-295(2000) · UniProtKB (1) |
| No evidence of linkage or diabetes-associated mutations in the transcription factors BETA2/NEUROD1 and PAX4 in Type II diabetes in France. Dupont S., Vionnet N., Chevre J.C., Gallina S., Dina C., Seino Y., Yamada Y., Froguel P. Diabetologia 42:480-484(1999) · Mapped (6) |
| Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Chevre J.-C., Hani E.H., Boutin P., Vaxillaire M., Blanche H., Vionnet N., Pardini V.C., Timsit J., Larger E., Charpentier G. et al. Diabetologia 41:1017-1023(1998) · UniProtKB (1) · Mapped (17) |
| No association between the Friedreich's ataxia gene and NIDDM in the French population. Dupont S., Dubois D., Vionnet N., Boitard C., Caillat-Zucman S., Timsit J., Froguel P. Diabetes 47:1654-1656(1998) · Mapped (3) |
| A missense mutation in hepatocyte nuclear factor-4-alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. Hani E.H., Suaud L., Boutin P., Chevre J.-C., Durand E., Philippi A., Demenais F., Vionnet N., Furuta H., Velho G. et al. J. Clin. Invest. 101:521-526(1998) · UniProtKB (1) |
| Identification of glucokinase mutations in subjects with gestational diabetes mellitus. Stoffel M., Bell K.L., Blackburn C.L., Powell K.L., Seo T.S., Takeda J., Vionnet N., Xiang K.-S., Gidh-Jain M., Pilkis S.J. et al. |
| Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Gidh-Jain M., Takeda J., Xu L.Z., Lange A.J., Vionnet N., Stoffel M., Froguel P., Velho G., Sun D., Cohen D. et al. Proc. Natl. Acad. Sci. U.S.A. 90:1932-1936(1993) · UniProtKB (1) |
| Structure/function studies of human beta-cell glucokinase. Enzymatic properties of a sequence polymorphism, mutations associated with diabetes, and other site-directed mutants. Takeda J., Gidh-Jain M., Xu L.Z., Froguel P., Velho G., Vaxillaire M., Cohen D., Shimada F., Makino H., Nishi S. et al. J. Biol. Chem. 268:15200-15204(1993) · UniProtKB (1) |
| Six mutations in the glucokinase gene identified in MODY by using a nonradioactive sensitive screening technique. Hager J., Blanche H., Sun F., Vionnet N., Vaxillaire M., Poller W., Cohen D., Czernichow P., Velho G., Robert J.-J. et al. Diabetes 43:730-733(1994) · UniProtKB (1) |
| Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. Byrne M.M., Sturis J., Clement K., Vionnet N., Pueyo M.E., Stoffel M., Takeda J., Passa P., Cohen D., Bell G.I. J. Clin. Invest. 93:1120-1130(1994) |
| A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Hager J., Hansen L., Vaisse C., Vionnet N., Philippi A., Poller W., Velho G., Carcassi C., Contu L., Julier C. Nat. Genet. 9:299-304(1995) · Mapped (3) |
| Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Gremlich S., Porret A., Hani E.H., Cherif D., Vionnet N., Froguel P., Thorens B. Diabetes 44:1202-1208(1995) · UniProtKB (1) |
| Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Vionnet N., Stoffel M., Takeda J., Yasuda K., Bell G.I., Zouali H., Lesage S., Velho G., Iris F., Passa P. Nature 356:721-722(1992) · Mapped (4) |
| Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Stoffel M., Froguel P., Takeda J., Zouali H., Vionnet N., Nishi S., Weber I.T., Harrison R.W., Pilkis S.J., Lesage S. et al. Proc. Natl. Acad. Sci. U.S.A. 89:7698-7702(1992) · UniProtKB (1) |